Informed Consent Should Address Standard Of Care Risks, US FDA’s Califf Says

 
• By Michael McCaughan
  
Information gaps still exist in informed consent documents, even though they are long and legalistic, FDA Commissioner Robert Califf said. (Shutterstock)

More from Clinical Trials

More from R&D